Use of duloxetine and chemotherapy drug in manufacture of pharmaceutical composition for treating or preventing cancer

TW202633602APending Publication Date: 2026-08-16LAUNXP BIOMEDICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115116161
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-22
Filing Date
2025-05-22
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073563_001
    Figure TWG2TA001073563_001
  • Figure TWG2TA001073563_002
    Figure TWG2TA001073563_002
  • Figure TWG2TA001073563_003
    Figure TWG2TA001073563_003
Patent Text Reader

Abstract

A use of duloxetine and chemotherapy drugs in the manufacture of a pharmaceutical composition for treating or preventing cancer, including administering an effective amount of duloxetine and chemotherapy drug to a subject in need thereof, which can brings about a better effect as compared with administering duloxetine or chemotherapy drugs alone.
Need to check novelty before this filing date? Find Prior Art